Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Asymmetric dimethylarginine (ADMA) is a naturally occurring amino acid found in tissues and cells that circulates in plasma and is excreted in urine. It inhibits nitric oxide synthases (NOs) and produces considerable cardiovascular biological effects. Several studies have suggested that plasma concentrations of ADMA provide a marker of risk for endothelial dysfunction and cardiovascular disease. In animal and in population studies ADMA has been associated with progression of CKD. Several mechanisms may be involved in this association, such as compromise of the integrity of the glomerular filtration barrier and development of renal fibrosis. This review summarizes the existing literature on the biology and physiology of ADMA focusing on its role in the progression of renal disease. © 2012 The Authors. Nephrology © 2012 Asian Pacific Society of Nephrology.


Vasileios Raptis, Stergios Kapoulas, Dimitrios Grekas. Role of asymmetrical dimethylarginine in the progression of renal disease. Nephrology (Carlton, Vic.). 2013 Jan;18(1):11-21

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 23016674

View Full Text